Conflict of Interest Disclosure

Similar documents
Conflict of Interest Disclosure

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

Testing the Asymptomatic CAD Patient: When and Why?

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Myocardial Perfusion: Positron Emission Tomography

The Role of Nuclear Imaging in Heart Failure

CT or PET/CT for coronary artery disease

Advantages of PET Myocardial Imaging

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Pearls & Pitfalls in nuclear cardiology

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Hybrid Imaging Improving Nuclear Cardiology Practice

Rational use of imaging for viability evaluation

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC

PET for the Evaluation of Myocardial Viability

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Welcome! To submit questions during the presentation: or Text:

Debate Should we use FFR? I will say NO.

Previous MI with no intervention

Rubidium-82 myocardial perfusion PET/CT

PET and PET/CT in CLINICAL CARDIOLOGY

New Challenges in Nuclear Cardiology Practice

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

Current and Future Imaging Trends in Risk Stratification for CAD

PET MYOCARDIAL PERFUSION AND QUANTIFICATION OF FLOW

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Case-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates

Coronary interventions

Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Preview of Presentation

Benefit of Performing PCI Based on FFR

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

PET myocard perfusion & viability Riemer Slart

NUCLEAR CARDIOLOGY UPDATE

PET MPI Limitations of SPECT MPI

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

63 yo woman with chest pain

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

Prognostic Value of Stress Myocardial Perfusion Positron Emission Tomography

Disclosure Information

Stress only Perfusion Imaging

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease-state-of-the-evidence and clinical recommendations

CHRONIC CAD DIAGNOSIS

PET: quantification of perfusion and beyond

CASE from South Korea

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan

Maria Angela S. Cruz-Anacleto, MD

New Insight about FFR and IVUS MLA

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Nuclear medicine in general practice. Dr Reza Garzan MD, FRACP, FAANMS

msv Stress dose (mci) Stress dose (MBq)

MD F A F C A C MAS A N S C

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

MINIMIZING RADIATION EXPOSURE

FFR-CT Not Ready for Primetime

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

FFR Incorporating & Expanding it s use in Clinical Practice

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

I have no financial disclosures

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Myocardial Perfusion SPECT How to do it E. Moralidis

INTRODUCTION. Key Words:

ORIGINAL ARTICLE. Diagnostic accuracy of high-resolution attenuation-corrected Anger-camera SPECT in the detection of coronary artery disease

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

CLINICAL CONSEQUENCES OF THE

2017 Qualified Clinical Data Registry (QCDR) Performance Measures

Calcium scoring Clinical and prognostic value

Patient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015

High Speed Myocardial Perfusion SPECT: Validation of Quantitative Analysis and use in Low Dose Stress only Protocol

Hybrid imaging of the heart

Assessment Of Myocardial Viability

Optimal Method for Stenosis Assessment with CT

CT Myocardial Perfusion: Is there Added Value to Coronary CT?

Cardiac PET. John Buscombe

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Dual Energy CT of the Heart: Perfusion and Beyond

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Physiological Assessment of Myocardial Perfusion Using Nuclear Cardiology Would Enhance Coronary Artery Disease Patient Care

State-of-the-Art SPECT/CT: Cardiac Imaging

FFR in Multivessel Disease

CT Perfusion. U. Joseph Schoepf, MD, FAHA, FSCBT MR, FSCCT Professor of Radiology, Medicine, and Pediatrics Director of Cardiovascular Imaging

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Medical Policy. MP Cardiac Applications of Positron Emission Tomography Scanning

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Risk Stratification for CAD for the Primary Care Provider

Transcription:

Comparative Advantages of PET Over SPECT: Is PET Really Better? Timothy M. Bateman M.D. Co-Director, Cardiovascular Radiologic Imaging Mid America Heart Institute Professor of Medicine University of Missouri-Kansas City Kansas City, Missouri Conflict of Interest Disclosure Dr. Bateman declares that the following relationships constitute a potential conflict of interest with respect to this presentation: Research Grants: Astellas, GE, Lantheus, Philips, SpectrumDynamics Advisory Boards: Astellas, GE, Lantheus, SpectrumDynamics Royalties: ExSPECT II TM, ImagenPro/MD/Q TM Stock Ownership: Cardiovascular Imaging Technologies

Comparative Advantages of PET for Myocardial Perfusion Imaging Improved image quality vs traditional SPECT Higher diagnostic accuracy More data to strengthen interpretive confidence Lower dosimetry vs rest/stress SPECT Better through-put efficiency (Rb-82) Spatially-centric vs spatially-relative Improved prognostication Situations When PET May Not Be Better Than SPECT for MPI Able to perform diagnostic-level exercise test Inability to lie still Slow circulation (CHF; PHTN) Rb-82 Morbid obesity Rb-82 Generator near EOL Rb-82 When adenosine only available vasodilator Rb-82

Pharmacologic Stress Myocardial Perfusion Imaging SPECT Rb-82 PET Mid-LAD Ischemia RCA Ischemia

SPECT PET 100 80 60 40 ACCURACY BY GENDER *p=0.05 84% 69% *p=0.01 88% 67% 100 80 60 40 ACCURACY BY BMI *p=0.05 87% 70% *p=0.02 85% 67% 20 20 0 Men Women 0 BMI<30 BMI>30 SPECT PET 100 80 60 40 20 MVD SENSITIVITY *p=0.03 71% 48% 0 MVD 90 80 70 60 50 40 30 20 10 0 Image Quality in 96 Pts Imaged With PET After a Non-Definitive SPECT Good Fair Sub-Optimal 18% SPECT vs 4% PET studies were in uncertain categories Yoshinaga, JACC 48: 1029 39, 2006 Bateman, JNC 13: 24 33, 2006

MIBI SPECT Rb 82 PET Diagnostic Accuracy, PET Less than 5% of this data is from PET/CT Beanlands and Youssef JNC 2010;17:683

SPECT, CMR, and PET for Detecting CAD Jaarsma et al J Am Coll Cardiol 2012; 59: 1719-1728 Rb-82 PET Vs SPECT for Diagnosis of Obstructive CAD: A Meta-Analysis PET SPECT McArdle et al, J Am Coll Cardiol 2012; 60: 1828-1837

Rb-82 PET Vs SPECT for Diagnosis of Obstructive CAD: A Meta-Analysis Including Direct PET/SPECT Comparison Studies McArdle et al, J Am Coll Cardiol 2012; 60: 1828-1837 Rb-82 PET Vs SPECT for Diagnosis of Obstructive CAD: A Meta-Analysis Including Only AC-SPECT p < 0.001 McArdle et al, J Am Coll Cardiol 2012; 60: 1828-1837

Information Content of a Contemporary PET MPI Study 1. High quality perfusion images: high count-density, minimal scatter, attenuation-corrected 2. High quality function images: each frame has high counts, each frame attenuation and scatter-corrected 3. Function images at rest and at peak stress (focus on changes in EF, ESV, average volume, & regional wall motion/thickening) 4. Rest and peak stress MBF 5. Presence and extent/severity of CAC 9 ma, 100 kvp, 5mm 5 secs breath-holding No ECG-gating ~ 0.18 msv 492 pts 6 independent readers CACS categorized as 0, 1-9, 10-99, 100-399, 400-999, > 1000 93% within 1 category Weighted kappa 0.89 Einstein et al, J Am Coll Cardiol 2010; 56: 1914-21

Rest EF 54% Peak Stress EF 60% Rest ESV 29 Peak Stress ESV 25 Coronary Artery Calcium Score 0 67 y/o woman with atypical angina, multiple risk factors, in hospital with acute pancreatitis Interpreted as low-risk scan, mild LAD distribution ischemia

One week later: Large anterior MI. Cath showed high-grade stenoses in the proximal and mid portions of the LAD coronary artery 59 y/o male normal PET MPI 1 month later = lateral MI Cath = LCx thrombus, 75% stenoses in LAD and RCA

Dosimetry Estimates for Radionuclide Myocardial Perfusion Imaging Tracer Stress Dose Rest Dose msv Tc-99m MIBI 30 mci 10 mci 12 msv Tc-99m MIBI SO 30 mci 9 msv Tc-99m MIBI SO-SD 2 4 mci 0.7 2 msv Rb-82 40 mci 40 mci 3.6 msv NH 3 -Ammonia 20 mci 20 mci 3 msv Rb-82 ECG-Gated Rest/Stress Acquisition Protocol for Dedicated or Hybrid PET/CT Rb-82 40 mci Dipyridamole, Dobutamine Stress Rb-82 40 mci 25 minutes 1 3.5 1 3.5 Tx Scan Emission Scan, 3D with gating Tx Scan Emission Scan, 3D with gating

PET MPI Risk Stratification % Abnl Myocardium As Function of LVEF Reserve Lertsburapa et al, JNC 15: 745-753, 2008 Dorbala et al, JACC Imaging 2009;2:846-854 MBFR Is an Independent Predictor of Major Adverse Cardiac Events (677 pts with median f/u 387days) Ziadi et al, JACC 2011; 58: 740-748

Improved Risk Assessment With PET CFR Murthy et al, Circulation October 17, 2011 Kaplan Meier Survival Curves Tonino PA et al. N Engl J Med 2009;360:213-224

PET Coronary Flow Reserve Vs Tracer Uptake Johnson et al, J Am Coll Cardiol Img 2012;5:193 202) Theoretic and Practical Benefit of PCI: CFR Vs FFR Johnson et al, J Am Coll Cardiol Img 2012;5:193 202)

Radionuclide Myocardial Perfusion Imaging in 2013: Moving Away From One Test For All Purposes MPI Stress-Only SPECT Rest/Stress SPECT Rest/Stress PET